A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

NCT03085914 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Epacadostat
DRUG: Pembrolizumab
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: 5-Fluorouracil
DRUG: Gemcitabine
DRUG: nab-Paclitaxel
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Pemetrexed
DRUG: Cyclophosphamide
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: 5-Fluorouracil
DRUG: Investigator's choice of platinum agent

Sponsor

Incyte Corporation